𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer

✍ Scribed by Ah Ram Chang; Hong-Gyun Wu; Charn Il Park; Yoon Kyung Jun; Chul-Woo Kim

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
182 KB
Volume
30
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

To evaluate the prognostic value of the expressions of epidermal growth factor receptor (EGFR) and cyclin D1 in early glottic cancer treated with radiotherapy only.

Methods

One hundred fifty‐one patients with T1‐2, N0 glottic cancer who had been treated with radiotherapy at Seoul National University Hospital since 1992 through 2004. Immunohistochemical staining for EGFR and cyclin D1 were performed on the formalin‐fixed paraffin‐embedded tissues of 25 patients who developed local recurrence and on the tissues of 25 matched patients free from disease. Patterns and degrees of expression were compared between these 2 groups.

Results

High EGFR (p = .047) and high cyclin D1 (p = .040) expressions were both found to be significantly associated with a poor prognosis. No association was found between EGFR and cyclin D1 status (p = .158), but EGFR and cyclin D1 status in combination were found to be significantly associated with local control. The patients with both high EGFR and high cyclin D1 expression had the poorest outcome compared with the others (14 months vs 29 months of median time to progression). Patterns of EGFR and cyclin D1 expression changed after recurrence, but these changes were not found to alter the ultimate prognosis.

Conclusion

The molecular biomarkers, EGFR and cyclin D1 have a prognostic significance in early glottic cancer. These markers in combination seem to play an important role in tumor relapse and may be useful for selecting patients with a poor outcome after radiotherapy. © 2008 Wiley Periodicals, Inc. Head Neck, 2008

📜 SIMILAR VOLUMES

Nuclear expression of epidermal growth f
Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer
✍ Weiya Xia; Yongkun Wei; Yi Du; Jinsong Liu; Bin Chang; Yung-Luen Yu; Long-Fei Hu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB

## Abstract The epidermal growth factor receptor (EGFR) has previously been detected in the nucleus of cancer cells and primary tumors. We have reported that EGFR translocates from the plasma membrane to the nucleus. Accumulation of nuclear EGFR is linked to increased DNA synthesis and proliferatio

Comparative analysis of epidermal growth
Comparative analysis of epidermal growth factor receptor mutations and gene amplification as predictors of gefitinib efficacy in Japanese patients with nonsmall cell lung cancer
✍ Takashi Sone; Kazuo Kasahara; Hideharu Kimura; Kazuto Nishio; Masayuki Mizuguchi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 1 views

## Abstract ## BACKGROUND. Because the investigation of epidermal growth factor receptor gene (__EGFR__) status as a predictor of gefitinib efficacy in Japanese patients has shown promise, the authors evaluated __EGFR__ mutations and gene amplification in biopsy specimens from Japanese patients wi

Evaluation of denaturing high-performanc
Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancer
✍ Victor Cohen; Jason S. Agulnik; Jonathan Jarry; Gerald Batist; David Small; Harv 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 1 views

## Abstract ## BACKGROUND. Somatic mutations of the epidermal growth factor receptor (__EGFR__) gene in nonsmall‐cell lung cancer (NSCLC) may predict responsiveness to tyrosine kinase inhibitors. These mutations are commonly identified using DNA sequencing methods. Although considered the gold sta